Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Conventional probe trabeculotomy versus microcatheter-assisted 360° trabeculotomy (PIRATE) in childhood glaucoma-study protocol for a randomized controlled trial.
Journal: Trials
Published: February 27, 2025
Early-life adversity as a predictor of fibromyalgia syndrome: the central role of perceived stress over endocrine stress indicators.
Journal: Pain
Published: July 16, 2024
Perceived and endocrine acute and chronic stress indicators in fibromyalgia syndrome.
Journal: Scientific reports
Published: June 25, 2024
Refocusing of Attention on Positive Events Using Monitoring-Based Feedback and Microinterventions for Patients With Chronic Musculoskeletal Pain in the PerPAIN Randomized Controlled Trial: Protocol for a Microrandomized Trial.
Journal: JMIR research protocols
Published: October 11, 2022
The PerPAIN trial: a pilot randomized controlled trial of personalized treatment allocation for chronic musculoskeletal pain-a protocol.
Journal: Pilot and feasibility studies
Published: December 27, 2021
Prolonged-Release (PR) Oxycodone/Naloxone Improves Bowel Function Compared with Oxycodone PR and Provides Effective Analgesia in Chinese Patients with Non-malignant Pain: A Randomized, Double-Blind Trial.
Journal: Advances in therapy
Published: December 17, 2019
Efficacy and tolerability of liposomal polyvinylpyrrolidone-iodine hydrogel for the localized treatment of chronic infective, inflammatory, dermatoses: an uncontrolled pilot study.
Journal: Clinical, cosmetic and investigational dermatology
Published: October 10, 2017
Authors' reply to the comment by Patel J, Martin JH and Lucas CJ.
Journal: European journal of pain (London, England)
Published: October 03, 2017
Efficacy of Conventional and Liposomal Povidone-Iodine in Infected Mesh Skin Grafts: An Exploratory Study.
Journal: Infectious diseases and therapy
Published: July 19, 2017
Long-term efficacy and safety of oxycodone-naloxone prolonged-release formulation (up to 180/90 mg daily) - results of the open-label extension phase of a phase III multicenter, multiple-dose, randomized, controlled study.
Journal: European journal of pain (London, England)
Published: March 15, 2017
A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR.
Journal: European journal of pain (London, England)
Published: March 11, 2017
Modified-release prednisone for polymyalgia rheumatica: a multicentre, randomised, active-controlled, double-blind, parallel-group study.
Journal: RMD open
Published: December 22, 2016
Last Updated: 09/26/2026